Singular Focus, Purpose-Built Solutions: Your Partner in Life Science Insurance

Berkley Life Sciences is solely dedicated to providing premiere insurance coverage for today’s top life sciences companies.

Life Sciences Insurance Life Sciences Insurance

Life Science Insurance Protecting Tomorrow’s Innovations

Comprehensive. Customized. Multinational. We provide property and casualty insurance products and services tailored to life science businesses globally. Our approach is collaborative, with underwriting, in-house claims, and risk management working in tandem to provide a complete and specialized insurance solution.

Why Berkley Life Sciences

Learn More About Us
Learn More About Us

Our Products

life sciences insurance

Primary

Primary

Through our LS Prime® and LS Prime® Advantage options, primary insurance coverage is offered as an admitted or non-admitted primary insurance solution.

Excess

Excess

Excess liability coverage of up to $15 million is available to protect a policyholder against unforeseeable catastrophic liability judgments.

Package

Package

Your comprehensive solution, our package product provides premises operations, property, commercial auto, workers compensation, crime, and umbrella coverage.

Multinational

Multinational

Addressing localized needs of customers in more than 90 countries around the world, we offer an integrated global solution through our LS Prime® specialty coverage including Foreign Clinical Trials, Local Products policy placements and Local Admitted Package policies.

In-House Claims

From the start of the underwriting process, our in-house claims team is a true partner in your insurance experience. With extensive life science products liability claim and litigation expertise, our claims team collaborates with insureds, brokers, and our defense counsel to actively lead claims to just resolution.

Discover Our Claims Difference

The Power of Berkley

Berkley Life Sciences is one of the 55+ (re)insurance businesses worldwide that comprise the Berkley brand. Berkley is one of America’s largest commercial lines property casualty insurance providers, operating worldwide within two segments of the P&C insurance business: Insurance and Reinsurance & Monoline Excess. Each business offers expertise within an industry, product, or region. 

 

Berkley Life Sciences is a member of W. R. Berkley Corporation, a Fortune 500 company listed on the New York Stock Exchange and is part of the S&P 500. W. R. Berkley Corporation’s insurance company subsidiaries are rated A+ (Superior), Financial Size Category XV by A.M. Best Company and A+ (Strong) by Standard & Poor’s. 

 

Berkley’s competitive advantage lies in its long-term strategy of decentralized operations. This structure provides each Berkley business the agility of a small business—the ability to identify and respond quickly and effectively to changing market conditions and local customer needs. It provides our Berkley businesses with the strength and resources of a Fortune 500 organization as well as the financial accountability and incentives to attract and retain the highest-caliber professionals.

Learn More About W. R. Berkley Corporation
W. R. Berkley headquarters W. R. Berkley headquarters

The Latest in Life Science

Protecting Life Sciences Property on the Move

Protecting Life Science Property on the Move

In the life sciences industry, innovation does not stop at the lab bench—it extends across the entire supply chain. As companies develop increasingly complex and sensitive products such as biologics, vaccines, and cell and gene therapies, the challenge of safely transporting these high-value assets has never been more critical. The journey from manufacturing site to end-user is fraught with risk, and even a minor disruption can result in significant financial loss, regulatory complications, and—most importantly—threats to patient safety.

Transforming Global Trade: The Power of Tariff Optimization Software

Transforming Global Trade: The Power of Tariff Optimization Software

Not long ago, tariff classification and associated payments were accepted as the cost of doing business. Trade professionals have long navigated free trade agreements, customs codes, and supply chain disruptions—often without specialized tools. But today’s global economy demands more.

Litigation Financing Tax Proposal: A Life Sciences Perspective

Litigation Financing Tax Proposal: A Life Sciences Perspective

Through the month of June and into the week of July 4th, 2025, national attention was largely focused on a sweeping federal spending bill moving through Congress as part of the budget reconciliation process. But while media and public attention was centered on healthcare and social welfare funding, most Americans were not aware that the bill also briefly included a contentious litigation finance tax proposal.